VERIFIEDET Finance·11 Jul 2026negative

Maharashtra FDA bars sale of two Cadila drugs over branding concerns

AI Summary

·Maharashtra FDA seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore.
·Sales of Aciloc 150 Plus and Aciloc 300 Plus were barred due to similar branding on different active ingredients.
·The action aims to prevent medication errors and safeguard public health.